Dr. Amy C Schefler , MD
Ophthalmology โข Houston, TX
6560 Fannin St, Suite 750
Houston, TX 770302761
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 8, 2007; this date does not establish years in practice.
-
Published CMS data list 7,654 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- G2212 โ Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or: 1,201 service units.
- J2781 โ Injection, pegcetacoplan, intravitreal, 1 mg: 1,155 service units.
- 92134 โ Imaging of retina: 1,100 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 22 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 353 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Erythromycin (Erythromycin Base) โ 83 prescription fills, including refills.
- Prednisolone Acetate โ 79 prescription fills, including refills.
- Ondansetron Odt (Ondansetron) โ 44 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 8 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: 1,290. Middle half: 512 to 2,999.
More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 8,404 in 2020 to 7,654 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
6560 Fannin St
Suite 750
Houston, TX 770302761
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Retina Consultants Of Houston Pllc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Js Weill Medical College, Cornell University
2003
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
610 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $1,543,387 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $1,219,097 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
482 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$8,046 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,502.99 across 15 records.
By nature of payment
- Honoraria: $3,820.00 across 1 record.
- Food and Beverage: $471.95 across 11 records.
- Travel and Lodging: $211.04 across 3 records.
Reporting-company totals (3 largest of 4)
- Immunocore Limited: $4,319.54 across 8 records.
- Regeneron Pharmaceuticals, Inc.: $120.43 across 5 records.
- ABBVIE INC.: $33.10 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
23 years (graduated 2003)
CMS Doctors and Clinicians data list 2003 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Schefler has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Schefler as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Houston and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: 1,290. Middle half: 512 to 2,999.
More Medicare Part B services than 85% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: $164,118. Middle half: $46,762 to $332,685.
A higher Medicare-allowed amount than 90% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Ophthalmology in Houston, TX (2024, 157 clinicians with data). Median for this group: $121,752. Middle half: $34,732 to $241,863.
A higher Medicare payment amount than 90% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.
Medicare Part D prescriptions
Fewer Part D prescriptions than 65% of clinicians listed under Ophthalmology in Houston, TX (2024, 175 clinicians with data). Median for this group: 655. Middle half: 221 to 2,095.
Fewer Part D prescriptions than 70% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.
Part D drug cost
A lower Part D drug cost than 75% of clinicians listed under Ophthalmology in Houston, TX (2024, 175 clinicians with data). Median for this group: $43,974. Middle half: $8,242 to $251,495.
A lower Part D drug cost than 80% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.
262 active clinicians are listed under Ophthalmology with a practice address in Houston, TX (1,517 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Houston
1.9% of these 262 clinicians have the CMS telehealth indicator.
64.1% of these 262 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services varied from year to year: 8,404 in 2020 and 7,654 in 2024.
- 2020: 8,404
- 2021: 8,506
- 2022: 6,308
- 2023: 12,069
- 2024: 7,654
-
Medicare-allowed amount
Medicare-allowed amount decreased 29% from $2,159,846 in 2020 to $1,543,387 in 2024.
- 2020: $2,159,846
- 2021: $2,062,529
- 2022: $1,579,512
- 2023: $1,527,477
- 2024: $1,543,387
-
Paid by Medicare
Paid by Medicare decreased 29% from $1,705,947 in 2020 to $1,219,097 in 2024.
- 2020: $1,705,947
- 2021: $1,630,429
- 2022: $1,240,528
- 2023: $1,201,725
- 2024: $1,219,097
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 77% from 200 in 2020 to 353 in 2024.
- 2020: 200
- 2021: 231
- 2022: 151
- 2023: 146
- 2024: 353
-
30-day fills
30-day fills increased 69% from 286 in 2020 to 482 in 2024.
- 2020: 286
- 2021: 332
- 2022: 249
- 2023: 209
- 2024: 482
-
Part D drug cost
Part D drug cost increased 60% from $5,042 in 2020 to $8,046 in 2024.
- 2020: $5,042
- 2021: $7,597
- 2022: $4,315
- 2023: $3,817
- 2024: $8,046
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $84.29 in 2021 to $4,502.99 in 2025.
- 2021: $84.29
- 2022: $3,325.68
- 2023: $264.51
- 2024: $1,757.01
- 2025: $4,502.99
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 15 records totaling $4,502.99.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Immunocore Limited |
Honoraria
Cash or cash equivalent
|
KIMMTRAK | General | $3,820.00 |
| Immunocore Limited |
Travel and Lodging
In-kind items and services
|
KIMMTRAK | General | $163.64 |
| Immunocore Limited |
Food and Beverage
In-kind items and services
|
KIMMTRAK | General | $97.12 |
| Immunocore Limited |
Food and Beverage
In-kind items and services
|
KIMMTRAK | General | $70.96 |
| Immunocore Limited |
Food and Beverage
In-kind items and services
|
KIMMTRAK | General | $62.24 |
| Immunocore Limited |
Food and Beverage
In-kind items and services
|
KIMMTRAK | General | $58.18 |
| Immunocore Limited |
Travel and Lodging
Cash or cash equivalent
|
KIMMTRAK | General | $42.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
OZURDEX | General | $33.10 |
| Genentech, Inc. |
Food and Beverage
In-kind items and services
|
Vabysmo | General | $29.92 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $29.92 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $28.65 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $22.34 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $20.98 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
EYLEA HD | General | $18.54 |
| Immunocore Limited |
Travel and Lodging
Cash or cash equivalent
|
KIMMTRAK | General | $5.40 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
G2212
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or
|
1,201 | 138 | $150.00 | $33.71 |
|
J2781
Injection, pegcetacoplan, intravitreal, 1 mg
|
1,155 | 11 | $451.00 | $146.75 |
|
92134
Imaging of retina
|
1,100 | 483 | $127.00 | $39.92 |
|
J0177
Injection, aflibercept hd, 1 mg
|
1,040 | 19 | $920.40 | $300.62 |
|
67028
Injection of drug into eye
|
604 | 126 | $488.95 | $135.95 |
|
J0178
Injection, aflibercept, 1 mg
|
580 | 59 | $2680.98 | $814.18 |
|
92014
Established patient complete exam of visual system
|
489 | 294 | $396.00 | $127.79 |
|
J2778
Injection, ranibizumab, 0.1 mg
|
294 | 15 | $775.00 | $161.78 |
|
76510
1d and 2d ultrasound scan of eye tissue and structures
|
292 | 177 | $216.75 | $69.20 |
|
76512
2d ultrasound scan of eye tissue and structures
|
255 | 166 | $151.00 | $48.69 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
230 | 137 | $563.00 | $185.60 |
|
76513
Ultrasound scan of eye using water bath method
|
92 | 79 | $236.40 | $76.02 |
|
J3590
Unclassified biologics
|
67 | 19 | $7989.94 | $2620.84 |
|
92004
New patient complete exam of visual system
|
65 | 65 | $469.00 | $152.19 |
|
92250
Photography of the retina
|
37 | 32 | $116.00 | $36.03 |
|
92285
Photography of content of eyes
|
34 | 29 | $148.00 | $20.17 |
|
67415
Fine needle aspiration of orbital contents
|
29 | 25 | $315.00 | $57.86 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
24 | 24 | $689.00 | $229.75 |
|
67218
Destruction of growth of retina by implantation of radiation source
|
18 | 18 | $4300.00 | $1467.02 |
|
76512
2d ultrasound scan of eye tissue and structures
|
18 | 18 | $151.00 | $31.78 |
|
67220
Destruction of vascular growth between retina and sclera by photocoagulation
|
16 | 16 | $1645.00 | $378.19 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
14 | 14 | $521.00 | $173.17 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Erythromycin | Erythromycin Base | 83 | 1,045 | $907.34 | 53 |
| Prednisolone Acetate | Prednisolone Acetate | 79 | 3,978 | $4,204.57 | 59 |
| Ondansetron Odt | Ondansetron | 44 | 265 | $253.18 | 40 |
| Atropine Sulfate | Atropine Sulfate | 42 | 1,807 | $1,661.64 | 39 |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 36 | 1,528 | $248.16 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 33 | 211 | $371.78 | 33 |
| Latanoprost | Latanoprost | 18 | 688 | $154.78 | โ |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 18 | 1,214 | $244.08 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0107X
An ophthalmologist who specializes in the diagnosis and treatment of vitreoretinal diseases.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20120607000697
TX
8527146455
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Retina Consultants Of Houston Pllc
4460 Bissonnet St, Bellaire, TX 774013234
Phone: 7135243434
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Medicine (M.D.), Master of Business Administration
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 6560 FANNIN ST, SUITE 750, HOUSTON, TX 770302761 (Tel: 7135243434)
Registered at 6560 FANNIN ST, SUITE 750, HOUSTON, TX 770302761 (Tel: 7135243434)
Recorded as AMY SCHEFLER, M.D.
Ophthalmology (license number reported to NPPES: TX P2782)
NPI status registered as active in NPPES database
Registered at 6560 FANNIN ST, SUITE 750, HOUSTON, TX 770302761 (Tel: 7135243434)
Registered at 6560 FANNIN ST, SUITE 750, HOUSTON, TX 770302761 (Tel: 7135243434)
Recorded as AMY SCHEFLER, M.D.
Ophthalmology (license number reported to NPPES: TX P2782)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Houston
- Dr. James Chong, MD
- Dr. Chia-Kai Chu, MD
- Dr. Omar Ismail, MD
- Dr. Belu Allam, MD
- Dr. Marc Sanders, MD, PA
- Dr. Rahul Pandit, MD
Mailing Address
6560 Fannin St, Suite 750
Houston, TX 770302761
Phone: 7135243434